For some fans of Modi, so far, so disappointing

August 13, 2014

Modi fansNew Delhi, Aug 13: As an election campaigner, Narendra Modi promised sweeping market reforms to revive India's economy and put the country to work. As prime minister, he has dismayed admirers, apparently reverting to the script of the hapless government he defeated.

To some of the economists and business leaders who as his campaign cheerleaders dared to dream of a Thatcherite revolution, he seems not to be listening. Three months after his win, it is dawning on them that their views count for little.

"As of now, the momentum is lost. They might still recover it, but we have lost the moment," said Bibek Debroy, a prominent economist who co-wrote a book laying out a reform agenda that the new prime minister himself launched in June.

Debroy told Reuters that so far there had been no signs of the promised change at institutions sapped by graft and over-regulation that many Indians have grown to revile.

Back in the heady days of the election campaign, Modi and his supporters seemed much more in tune, all lambasting the last centre-left government for years of waste and policy paralysis and building expectations of a regime of "minimum government and maximum governance" that would unshackle key sectors of the economy from the state.

But now there is a sense that the 63-year-old Bharatiya Janata Party (BJP) strongman, who made his reputation putting his home state Gujarat on a high growth path, has somehow stumbled in New Delhi.

To be fair, the government has a five-year term to achieve Modi's goal of transforming India into an economic and military power able to withstand the rise of China on its doorstep.

On Friday, Modi will make his first Independence Day speech from the ramparts of the Red Fort in Old Delhi, and the expectation within his party is that he may use the occasion to announce bold changes that have so far been absent.

According to economists at HSBC, the government has already moved with "unaccustomed alacrity" on a number of fronts, such as opening up the state railways to foreign investment and providing new guidelines for a more streamlined bureaucracy.

"But the stuff that will lift economic growth over time ... requires deft and delicate handling," they said this week, noting resistance to reform from the country's states and the challenges of pushing legislation through the upper house of parliament, where the BJP does not have a majority.

MORE OF THE SAME

Modi won India's biggest election mandate in three decades in May after promising to revive growth that has fallen below 5 percent, choking off job opportunities for the one million people who enter the workforce every month.

He dangled the prospect of new roads, factories, power lines, high-speed trains and even 100 new cities. So far, there has been little movement on any of these gigantic tasks, which will require an overhaul of India’s land acquisition laws, faster environmental clearances and an end to red tape.

He has refrained from cutting food aid that is estimated to cost 1 percent of gross domestic product, or tackling costly welfare programmes.

Last month, his government blocked a global trade reform pact, saying there must be movement on a parallel agreement on stockpiling that is necessary to run a programme to distribute cheap food, the world's largest.

A leader with such a strong mandate "should be making policy with conviction, not emulating tactics of a defunct government," Surjit Bhalla, an economist and bitter critic of the previous government, wrote in the Indian Express newspaper.

BJP leaders and strategists with ties to the Modi administration said the government had considered reforms to a $6 billion workfare scheme that guarantees 100 days of employment a year to the rural poor.

One idea was to take modest steps that would cut waste, stop unproductive work and tackle embezzlement, said a source with knowledge of the discussions within the government. But the government shrank back even from that, and actually increased funding for the scheme in its budget for fiscal 2014-15.

It was not clear who vetoed the changes, but the source said some were pointing the finger at India's powerful bureaucracy.

TWEETING BUT NOT TALKING

Modi himself has not been speaking much, and that has compounded the problem, said a member of his campaign team.

Modi the campaigner was everywhere, even appearing as an animated hologram in places he couldn't visit. Modi the premier has been low-profile, preferring to communicate through Twitter.

His reluctance to engage the media has drawn parallels with his reserved predecessor, Manmohan Singh, although the two men could hardly be more dissimilar.

"Manmohan Singh's silence was out of compulsion, Modi's by choice," said the election strategist.

Some of Modi's top-ranking supporters including top Columbia University economist Jagdish Bhagwati, who hailed his rise as a turning point for India, have yet to find a role in his team.

Bhagwati, who told Reuters in April that he expected a spot on an external council advising the prime minister, declined to comment on the government's performance so far, saying he was recovering from surgery.

He noted in an email, however, that there had been mixed reactions to Modi's first three months.

Arvind Panagariya, Bhagwati's protege at Columbia, had nothing to add to an article he wrote last month criticising Modi for continuing wasteful subsidies and sticking to a fiscal deficit target that he believes will throttle growth.

Panagariya has taken on a role advising the government of Rajasthan, a BJP-led state that has since the election rolled out the sort of ambitious reforms Modi fans had hoped he would embrace for the nation as a whole.

MODI THE CEO

While Modi is yet to unveil major policy initiatives, he has been unrelenting in his focus on making government accountable and holding his ministers to high standards of public probity.

Cabinet colleagues routinely field calls at the crack of dawn or late at night from the prime minister's office, often to check on work in progress.

Modi himself works 15-hour days and at weekends, and expects similar commitment from members of his government.

One minister was refused permission to go on a private trip abroad to attend his daughter's graduation. He was told that, if he really had to go, he should give up his post. Another, on his way to the airport for an official tour, was told to dress appropriately since he was representing his country.

"To be fair, Modi has been taking quite a few incremental measures, which will make it easier to do business in India," a banker said, on condition of anonymity.

"People pay little attention to nuts and bolts reforms as they don't make headlines, but they count a lot."

At least one prominent Western investor is voting with his feet.

U.S. real estate mogul Donald Trump said on Tuesday he planned "substantial investments" in Indian property and hotels, betting on the new government to revive economic growth.

"I do see India as a great place to invest, and I think the election made that even better," said Trump, in India to launch Trump Tower in Mumbai, his first project in the country's financial capital, in collaboration with India's Lodha Group.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 23,2020

Jerusalem, Jul 23: Merging Israel's technological expertise with India's mass production capabilities, experts from the two countries have joined hands to develop rapid testing for Covid-19 in under 30 seconds.

Israel will soon send a high-level research delegation to India to conduct a series of "final stages of testing" as part of the joint effort to develop the rapid testing kits for Covid-19 .

A high ranking team from the Directorate of Defence Research and Development (DDR&D), in the Ministry of Defense, which has been working with India's DRDO to develop rapid testing for Covid-19 in under 30 seconds, is to leave from Tel Aviv to New Delhi on a special flight in a few days, Israel's Ministry of Defence said in a statement on Thursday.

Israel's Ministry of Foreign Affairs (MFA) and Ministry of Health are also involved in this unprecedented cooperation between the two countries which aims at "merging Israeli technology with Indian development and production capabilities to allow a swift resumption of normal life alongside the virus".

The DDR&D team will conduct a series of "final stages of testing" to determine the effectiveness of a number of rapid diagnostic solutions with their Indian counterparts.

Since the start of the pandemic, the DDR&D has tested dozens of diagnostic technologies. Some of them have matured and passed initial trials in Israel, however in order to complete testing and prove their effectiveness, these must be tested on a wide range of patients, IMoD said.

The four tech systems that will be tested are - voice test, breathalyzer test based on terra-hertz waves, isothermal test, and polyamino acids test.

"What they all have in common is the ability to detect the presence of the virus in the body quickly- usually within minutes. Developing diagnostic capabilities is a goal for the State of Israel and of many additional countries around the world. It is the most effective way to cut off 'chains of infection', prevent prolonged quarantine and enable the reopening of the global economy," the statement said.

"We hope that the research and development led by the DDR&D together with our excellent industries and academic institutions, will lead to a breakthrough that will change the way we diagnose and fight the virus, while giving the boost necessary to 'restart' our economy," Defense Minister Benny Gantz said.

Foreign Minister Gabi Ashkenazi noted that this cooperation provides a unique opportunity for scientific and technological cooperation that can assist Israel, India and the world in coping both with the pandemic and with the economic crisis that came with it.

The cooperation between Israel and India will enable the delegation and its Indian counterparts, to collect tens of thousands of samples in just ten days, and analyze them using computer systems based on artificial intelligence. This massive sampling will shorten processes and advance the approval of effective technology. All tests will be validated using PCR tests.

"The cooperation between India and Israel on Covid-19 is a good example of harnessing the scientific and technological strengths that the two countries have for larger, common good. It will also further deepen our strategic ties,” India's Ambassador Sanjeev Singla told PTI.

The flight will be carrying some breakthrough emerging Israeli technologies for combatting Covid-19, which have been donated by the Israeli foreign ministry and the private sector, in order to bolster India’s response to the virus outbreak.

The plane will also deliver mechanical ventilators which were given special permission by Israel for export to India.

Prime Minister Narendra Modi and his Israeli counterpart Benjamin Netanyahu have held three telephonic conversations since the outbreak of the pandemic and promised mutual assistance in dealing with the virus, committing to joint technological and scientific research between the countries.

The Israeli media widely reported that Modi lifted a ban on the export of Hydroxychloroquine at Netanyahu's request.

"The past few years have cemented the strategic relations between India and Israel and have included two historical visits of the Prime Ministers in Israel and in India," a press statement from the ministry of defence said.

"India seeks to integrate advanced technologies in its hospitals as they prepare to treat massive waves of Covid-19 patients on an Indian scale. The Israeli companies chosen by the MFA, MOD and Israel Defence Forces to be sent to India are potentially given unique access to one of the largest economies in the world to provide monitoring and treatment technologies while significantly reducing contact between the patients and the medical staff," it said.

"By opening the door to India’s market with its development and production capabilities, these Israeli technologies can be mass produced at a lower cost and could in future be jointly exported to third countries," it said.

"The COVID-19 pandemic is a global challenge, so it is only right that the solution be a global scientific cooperation between countries. India and Israel’s military R&D cooperation is well known for its success. I have no doubt the same will be seen in the private sector joined by brilliant scientific minds from both countries to introduce a breakthrough in swift and simple testing procedures,” said Prof. Nati Keller, an infectious diseases specialist from Sheba Medical Center, who is leading the medical side of the delegation.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 13,2020

New Delhi, Apr 13: India's tally of positive COVID-19 cases rose to 9,152 following an increase of 796 cases in the last 24 hours, the Union Ministry of Health and Family Welfare said on Monday.

Out of the total number of cases, 7,987 patients are active cases while 857 cases have been cured/discharged and migrated.

With 35 deaths in the last 24 hours, the death toll mounted to 308.

According to the ministry, Maharashtra remained at the top with the total cases at 1,985, including 217 patients who have recovered/discharged and 149 patients died.

Delhi's tally of positive COVID-19 cases rose to 1,154 cases, including 27 recovered and 24 patients succumbing to the virus.

Tamil Nadu too reported 1,075 cases, including 50 recovered and 11 patients dead.

Meanwhile, four states have crossed the 500 mark with regards to the total number of cases as Rajasthan recorded 804 cases, Madhya Pradesh with 532 cases, Gujarat with 516 cases and Telangana with 504 cases, as per the ministry.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.